Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw strong trading volume on Friday . 15,469 shares changed hands during trading, an increase of 72% from the previous session’s volume of 8,984 shares.The stock last traded at $17.02 and had previously closed at $16.00.

Wall Street Analysts Forecast Growth

TLX has been the subject of a number of analyst reports. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They issued a “buy” rating and a $21.00 price target for the company. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 4.9 %

The firm has a 50 day moving average of $15.64.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.